BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1728 related articles for article (PubMed ID: 27749791)

  • 1. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.
    Otsubo M; Kinouchi R; Kamiya T; Yoshida A
    J Med Case Rep; 2021 Jul; 15(1):355. PubMed ID: 34284818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
    Rahman HT; Yeh S; Bergstrom CS
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Fiscella RG; Adelman AE
    Retina; 1997; 17(3):222-31. PubMed ID: 9196934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.
    Nomi N; Ota M; Fukumura M; Nuno Y; Hatano M; Wakuta M; Yanai R; Kimura K
    Jpn J Ophthalmol; 2018 Mar; 62(2):163-167. PubMed ID: 29270811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOPICAL DORZOLAMIDE FOR CYSTOID MACULAR EDEMA IN BIETTI CRYSTALLINE RETINAL DYSTROPHY.
    Khojasteh H; Roohipoor R; Riazi-Esfahani H; Ghasempour M
    Retin Cases Brief Rep; 2021 May; 15(3):306-309. PubMed ID: 30028788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
    Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
    Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I
    Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.
    Ikeda Y; Yoshida N; Notomi S; Murakami Y; Hisatomi T; Enaida H; Ishibashi T
    Br J Ophthalmol; 2013 Sep; 97(9):1187-91. PubMed ID: 23782868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: RESPONSE TO TOPICAL DORZOLAMIDE THERAPY.
    Ajlan RS; Hammamji KS
    Retin Cases Brief Rep; 2019; 13(4):364-366. PubMed ID: 28557864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
    Liew G; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.
    Rahimy E; Sarraf D
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):187-9. PubMed ID: 23421925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
    Genead MA; Fishman GA
    Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory.
    Kanakis M; Georgalas I; Makatsoris T; Pharmakakis N
    Curr Drug Saf; 2019; 14(1):43-47. PubMed ID: 30156164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment.
    Tezcan Y; Surmeli M; Tastekin D; Koc M
    Arch Iran Med; 2015 Sep; 18(9):606-7. PubMed ID: 26317603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
    Zhang HR; Wang X; Lu XR; Yang YF; Liu F
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of cystoid macular edema associated with Paclitaxel chemotherapy.
    Ham DS; Lee JE; Kim HW; Yun IH
    Korean J Ophthalmol; 2012 Oct; 26(5):388-90. PubMed ID: 23060727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Apushkin MA; Fishman GA
    Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy.
    Kim DG; Yoon CK; Kim HW; Lee SJ
    Can J Ophthalmol; 2018 Jun; 53(3):e103-e107. PubMed ID: 29784170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 87.